Cellular receptors and hantavirus pathogenesis.
Hantaviruses cause two potentially lethal diseases, HPS and HFRS, and both diseases result in defects in vascular permeability and platelet function. Human beta 3 integrins confer cellular susceptibility to HPS- and HFRS-causing hantaviruses, a fact directly linking platelets, endothelial cells, and hantavirus diseases to the use of [figure: see text] cellular receptors that maintain capillary integrity and regulate platelet function. The role of vitronectin, PAI-1, uPAR, and complement cascades in hantavirus pathogenesis are unstudied but may contribute to specific disease syndromes effected by hantaviruses. The divergence of hantavirus surface glycoproteins and common beta 3-integrin usage provides further insight into the interaction of hantaviruses with cells. G1 and G2 glycoprotein variation is likely to contribute to additional interactions that determine pathogenic responses to individual viruses. beta 3-integrin usage also suggests that common elements exist on G1 or the more highly conserved G2 surface glycoprotein, which mediate viral attachment to integrins. Although there is currently no data defining the virion attachment protein, the development of antibodies that recognize the hantavirus attachment protein and block integrin interactions is of interest since it is likely to provide an additional point for therapeutic intervention and vaccine development. There are a plethora of effects that could be elicited by hantavirus regulation of cellular beta 3 integrins and their ligands that are consistent with hantavirus diseases. Since beta 3 integrins are critical adhesive receptors on platelets and endothelial cells and regulate both vascular permeability and platelet activation and adhesion, the use of these receptors by hantaviruses is likely to be fundamental to hantavirus pathogenesis. The lack of an animal model for hantavirus pathogenesis has prevented a systematic analysis of immune and cellular responses to hantavirus infections, and it impedes our ability to study protective or therapeutic approaches to hantavirus diseases. However, recent findings suggest that human beta 3 integrins within transgenic mice may provide animal models of hantavirus pathogenesis and have the potential to radically alter the ability to investigate hantavirus disease.
Mackow
E R
ER
Department of Medicine, Stony Brook University, HSC T17, Room 60, Stony Brook, NY 11794, USA.
Gavrilovskaya
I N
IN
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism / Q000502:physiology; D001792:Blood Platelets / Q000821:virology; D004727:Endothelium / Q000166:cytology / Q000821:virology; D006476:Orthohantavirus / Q000378:metabolism / Q000472:pathogenicity*; D018778:Hantavirus Infections / Q000821:virology*; D018804:Hantavirus Pulmonary Syndrome / Q000821:virology; D006480:Hemorrhagic Fever with Renal Syndrome / Q000821:virology; D006801:Humans; D039661:Integrin beta3; D008024:Ligands; D008562:Membrane Glycoproteins / Q000502:physiology; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology; D010980:Platelet Membrane Glycoproteins / Q000378:metabolism / Q000502:physiology; D014764:Viral Proteins / Q000378:metabolism; D019096:Vitronectin / Q000502:physiology
D015703:Antigens, CD; D039661:Integrin beta3; D008024:Ligands; D008562:Membrane Glycoproteins; D017395:Plasminogen Activator Inhibitor 1; D010980:Platelet Membrane Glycoproteins; D014764:Viral Proteins; D019096:Vitronectin